Cancer is a complex disease with multifaceted causes and avenues for control. While genetic predispositions play a role, lifestyle factors such as tobacco use, unhealthy diet, lack of physical activity, and exposure to environmental carcinogens contribute significantly. Prevention strategies emphasize smoking cessation, adopting a balanced diet rich in fruits and vegetables, regular exercise, and minimizing exposure to harmful chemicals. Early detection through screening programs increases treatment success rates. Moreover, advancements in cancer research have led to innovative therapies like immunotherapy and targeted drug treatments, enhancing survival rates and quality of life for patients. Integrating these approaches fosters a comprehensive framework for cancer control, addressing both prevention and treatment aspects. Continued research and public health initiatives are pivotal in reducing the burden of cancer globally.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China